Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data
Amyotrophic lateral sclerosis (ALS) is an irreversible degenerative disease. Placebo-controlled randomized trials are currently the main trial design to assess the clinical efficacy of drugs for ALS treatment....
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Ruifen Cai, Juan Yang, Lijuan Wu, Yixiao Liu, Xinrui Wang, Qingshan Zheng and Lujin Li Tags: Research Source Type: research